Skip to main content

Advertisement

Log in

Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis

  • Invited Review
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

We sought to examine the literature reporting the effect of urinary tract infection (UTI) on non-schistosomiasis-related UBC (UBCNS) through a systematic review and meta-analysis.

Methods

A predefined study protocol was developed according to PRISMA. Medline and Scopus were searched for all studies investigating exposure to UTI with UBCNS as the primary outcome. Potential studies were screened against eligibility criteria. Clinical heterogeneity was assessed and groups with more than two studies were evaluated by random effect meta-analysis. Study-level bias was assessed with the Newcastle–Ottawa Scale (NOS). In cases of substantial between study heterogeneity (I2 > 50%), predefined sensitivity and subgroup analyses were performed.

Results

Of 16 eligible studies, eight case–control studies spanning four decades and five countries were suitable for quantitative analysis. Main analysis favored exposure to UTI increasing risk of subsequent UBCNS (RR 1.33 [95% CI 1.14–1.55]). This effect was no longer statistically significant after excluding studies published prior to year 2000 and at high risk of bias. Between study heterogeneity was considerable for nearly all analyses and not reduced by predefined sensitivity or subgroup analyses.

Conclusion

Exposure to UTI favors increased risk for UBCNS, particularly in men, but these effects were statistically insignificant when pooling data from the most recent and highest quality studies. These data do not support findings of previously published studies, that report on heterogenous populations with poor definitions of UTI and minimal control for important confounders. Results from previous studies should be viewed as hypothesis generating. This review highlights the need for higher quality investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

HR:

Hazard ratio

NOS:

Newcastle–Ottawa Scale

OR:

Odds ratio

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

PROSPERO:

International Prospective Register of Systematic Reviews

RR:

Risk ratio

SCC:

Squamous cell carcinoma

UBC:

Urinary bladder cancer

UBCNS :

Non-schistosomiasis-related UBC

UC:

Urothelial carcinoma

UTI:

Urinary tract infection

References

  1. International Agency for Research on Cancer Agents classified by the IARC monographs, vol. 1–118. http://monographs.iarc.fr/ENG/Classification/index.php. Accessed 21 Dec 2016

  2. Anderson-Otunu O, Akhtar S (2016) Chronic infections of the urinary tract and bladder cancer risk: a systematic review. Asian Pac J Cancer Prev 17:3805–3807

    PubMed  Google Scholar 

  3. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009(151):264–269

    Article  Google Scholar 

  4. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1

    Article  PubMed  PubMed Central  Google Scholar 

  5. Farah D, Hsieh M, Bayne C (2016) Role of urinary tract infection in non-schistosomiasis bladder cancer: protocol for a systematic review and planned meta-analysis. PROSPERO CRD42016053888. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016053888

  6. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Assessed December 12, 2016

  7. The Cochrane Collaboration (2011) 10.4.3.1 Recommendations on testing for funnel plot asymmetry. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. http://www.handbook.cochrane.org. Accessed 31 May 2016

  8. Sterne JA, Sutton AJ, Ioannidis JP et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials. BMJ 343:d4002

    Article  PubMed  Google Scholar 

  9. Review Manager (RevMan) (2014) [Computer program]. Version 5.3. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen

  10. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119:510–515

    Article  PubMed  CAS  Google Scholar 

  11. Kjaer SK, Knudsen JB, Sørensen BL, Møller Jensen O (1989) The Copenhagen case–control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol 28:631–636

    Article  PubMed  CAS  Google Scholar 

  12. Hartge P, Harvey EB, Linehan WM et al (1990) Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82:1636–1640

    Article  PubMed  CAS  Google Scholar 

  13. La Vecchia C, Negri E, D’Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629–631

    PubMed  Google Scholar 

  14. Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X (2007) Urinary tract diseases and bladder cancer risk: a case–control study. Cancer Causes Control 18:839–845

    Article  PubMed  Google Scholar 

  15. Jiang X, Castelao JE, Groshen S et al (2009) Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer 100:834–839

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Erdurak K, Dundar PE, Ozyurt BC, Negri E, La Vecchia C, Tay Z (2014) Smoking, occupation, history of selected diseases and bladder cancer risk in Manisa, Turkey. Eur J Cancer Prev 23:58–61

    Article  PubMed  CAS  Google Scholar 

  17. Vermeulen SH, Hanum N, Grotenhuis AJ et al (2015) Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 112:594–600

    Article  PubMed  CAS  Google Scholar 

  18. Howe GR, Burch JD, Miller AB et al (1980) Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 64:701–713

    PubMed  CAS  Google Scholar 

  19. Sullivan JW (1982) Epidemiologic survey of bladder cancer in greater New Orleans. J Urol 128:281–283

    Article  PubMed  CAS  Google Scholar 

  20. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H (1986) Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 124:578–589

    Article  PubMed  CAS  Google Scholar 

  21. Piper JM, Matanoski GM, Tonascia J (1986) Bladder cancer in young women. Am J Epidemiol 123(6):1033–1042

    Article  PubMed  CAS  Google Scholar 

  22. González CA, Errezola M, Izarzugaza I et al (1991) Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 27:498–500

    Article  PubMed  Google Scholar 

  23. Kunze E, Chang-Claude J, Frentzel-Beyme R (1992) Life style and occupational risk factors for bladder cancer in Germany. A case–control study. Cancer 69:1776–1790

    Article  PubMed  CAS  Google Scholar 

  24. D’Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J (1995) Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 5:427–431

    Article  PubMed  Google Scholar 

  25. Sun LM, Lin CL, Liang JA et al (2013) Urinary tract infection increases subsequent urinary tract cancer risk: a population-based cohort study. Cancer Sci 104:619–623

    Article  PubMed  CAS  Google Scholar 

  26. Seay TM, Peretsman SJ, Dixon PS (1996) Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol 155:757–762

    Article  PubMed  CAS  Google Scholar 

  27. Kamat AM, Lamm DL (2004) Antitumor activity of common antibiotics against superficial bladder cancer. Urology 63:457–460

    Article  PubMed  Google Scholar 

  28. Gui-Zhong L, Li-Bo M (2017) Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord 55:341–345

    Article  PubMed  CAS  Google Scholar 

  29. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the anonymous reviewers for their role in improving our manuscript.

Funding

CEB is supported by the Joseph E. Robert, Jr. Fellowship at the Sheikh Zayed Institute for Pediatric Surgical Innovation, part of the Children’s National Health System. MHH is supported by a National Institutes of Health R56 (AI119168) grant.

Author information

Authors and Affiliations

Authors

Contributions

CEB: Protocol/project development, data collection, data analysis, manuscript writing. DF: Protocol/project development, data collection. KWH: Data analysis. MHH: Protocol/project development.

Corresponding author

Correspondence to Christopher E. Bayne.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

For this type of study formal consent is not required.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human participants or animals performed by any of the authors.

Protocol registration

This study protocol (2016:CRD42016053888) was developed prior to data collection according to PRISMA and PRISMA-P guidelines and registered with the International Prospective Register of Systematic Reviews (PROSPERO): http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016053888.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 75 kb) Flow diagram of study selection

345_2018_2257_MOESM2_ESM.png

Supplementary material 2 (PNG 4 kb) Funnel plot illustrating risk ratio according to standard errorLegend: RR, risk ratio; SE, standard error; dashed line = overall effect; RR of 1 equates to no intervention effect

345_2018_2257_MOESM3_ESM.tif

Supplementary material 3 (TIFF 83 kb) Pooled analysis for exposure to UTI on risk of UBC according to sex. A) Males only. B) Females only

345_2018_2257_MOESM4_ESM.tif

Supplementary material 4 (TIFF 55 kb) Pooled analysis exposure to UTI on UBC risk according to smoking history*. A) With smoking history. B) Without smoking history. *Jiang et al data reported smoking data for women only and excluded data within 5 years of cancer diagnosis

345_2018_2257_MOESM5_ESM.tif

Supplementary material 5 (TIFF 63 kb) Pooled analysis for exposure to multiple UTI (versus no exposure) on risk of UBC*. A) Overall analysis. B) Analysis after excluding studies prior to year 2000 and with high risk of bias. * Jhamb et al excluded data within 3 years of cancer diagnosis; Jiang et al reported episodes of bladder infection for women only and excluded data within 5 years of cancer diagnosis

Supplementary material 6 (DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayne, C.E., Farah, D., Herbst, K.W. et al. Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis. World J Urol 36, 1181–1190 (2018). https://doi.org/10.1007/s00345-018-2257-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-018-2257-z

Keywords

Navigation